| 2009～2011年武汉地区抗肿瘤分子靶向治疗药物应用分析 |
| |
| 引用本文： | 张文婷,桂玲,刘东.2009～2011年武汉地区抗肿瘤分子靶向治疗药物应用分析[J].药物流行病学杂志,2013(1):32-34. |
| |
| 作者姓名： | 张文婷 桂玲 刘东 |
| |
| 作者单位： | 华中科技大学同济医学院附属同济医院 |
| |
| 摘 要： | 目的:了解武汉地区医院抗肿瘤分子靶向治疗药物的使用情况与特点。方法:对武汉地区32家医院2009～2011年抗肿瘤分子靶向治疗药物的应用品种、销售金额、用药频度(DDDs)及日均费用(DDC)等进行回顾性统计和分析。结果:武汉地区抗肿瘤分子靶向治疗药物销售金额与DDDs呈逐年增长趋势,DDC相对稳定。结论:2009～2011年武汉地区抗肿瘤分子靶向治疗药物应用状况和发展趋势较为合理。
|
| 关 键 词： | 抗肿瘤药 分子靶向治疗 销售金额 用药频度 日均费用 药物利用 |
Utilization of Antineoplastic for Molecular Target Therapy in Hospitals of Wuhan During 2009-2011 |
| |
| Zhang Wenting,Gui Ling,Liu Dong.Utilization of Antineoplastic for Molecular Target Therapy in Hospitals of Wuhan During 2009-2011[J].Chinese Journal of Pharmacoepidemiology,2013(1):32-34. |
| |
| Authors: | Zhang Wenting Gui Ling Liu Dong |
| |
| Affiliation: | Department of Pharmacy,Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430030,China |
| |
| Abstract: | ABSTRACT Objective:To investigate the utilization and characteristics of antineoplastic for molecular target therapy in hospitals of Wuhan.Methods:The utilization data of antineoplastic for molecular target therapy were statistically analyzed in 32 hospitals of Wuhan during 2009-2011 in terms of category,consumption sum,DDDs,and DDC. Results:The consumption sum and DDDs of antineoplastic for molecular target therapy were increasing year by year, and the DDC leveled off. Conclusion:The utilization of antineoplastic for molecular target therapy is reasonable. |
| |
| Keywords: | |
| 本文献已被 CNKI 等数据库收录！ |
